The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
Identifieur interne : 005F97 ( Main/Exploration ); précédent : 005F96; suivant : 005F98The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
Auteurs : Shefali Agrawal [États-Unis] ; John M. Kane ; Beverly A. Guadagnolo ; William G. Kraybill ; Matthew T. BalloSource :
- Cancer [ 0008-543X ] ; 2009.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Association thérapeutique, Dosimétrie en radiothérapie, Femelle, Humains, Lymphadénectomie, Mâle, Mélanome (), Mélanome (anatomopathologie), Mélanome (mortalité), Mélanome (radiothérapie), Métastase lymphatique, Radiothérapie adjuvante, Risque, Récidive tumorale locale, Sujet âgé, Sujet âgé de 80 ans ou plus, Taux de survie, Tumeurs cutanées (), Tumeurs cutanées (anatomopathologie), Tumeurs cutanées (mortalité), Tumeurs cutanées (radiothérapie).
- MESH :
- anatomopathologie : Mélanome, Tumeurs cutanées.
- mortalité : Mélanome, Tumeurs cutanées.
- radiothérapie : Mélanome, Tumeurs cutanées.
- Adolescent, Adulte, Adulte d'âge moyen, Association thérapeutique, Dosimétrie en radiothérapie, Femelle, Humains, Lymphadénectomie, Mâle, Mélanome, Métastase lymphatique, Radiothérapie adjuvante, Risque, Récidive tumorale locale, Sujet âgé, Sujet âgé de 80 ans ou plus, Taux de survie, Tumeurs cutanées.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Aged, 80 and over, Combined Modality Therapy, Female, Humans, Lymph Node Excision, Lymphatic Metastasis, Male, Melanoma (mortality), Melanoma (pathology), Melanoma (radiotherapy), Melanoma (surgery), Middle Aged, Neoplasm Recurrence, Local, Radiotherapy Dosage, Radiotherapy, Adjuvant, Risk, Skin Neoplasms (mortality), Skin Neoplasms (pathology), Skin Neoplasms (radiotherapy), Skin Neoplasms (surgery), Survival Rate.
- MESH :
- mortality : Melanoma, Skin Neoplasms.
- pathology : Melanoma, Skin Neoplasms.
- radiotherapy : Melanoma, Skin Neoplasms.
- surgery : Melanoma, Skin Neoplasms.
- Adolescent, Adult, Aged, Aged, 80 and over, Combined Modality Therapy, Female, Humans, Lymph Node Excision, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Recurrence, Local, Radiotherapy Dosage, Radiotherapy, Adjuvant, Risk, Survival Rate.
Abstract
The objective of this study was to evaluate the impact of adjuvant radiation therapy (RT) on regional recurrence and survival after therapeutic lymphadenectomy (TL) for clinically advanced, lymph node-metastatic melanoma.
DOI: 10.1002/cncr.24627
PubMed: 19701906
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002D70
- to stream PubMed, to step Curation: 002D70
- to stream PubMed, to step Checkpoint: 002D70
- to stream Ncbi, to step Merge: 003576
- to stream Ncbi, to step Curation: 003576
- to stream Ncbi, to step Checkpoint: 003576
- to stream Main, to step Merge: 006068
- to stream Main, to step Curation: 005F97
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.</title><author><name sortKey="Agrawal, Shefali" sort="Agrawal, Shefali" uniqKey="Agrawal S" first="Shefali" last="Agrawal">Shefali Agrawal</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgical Oncology, Roswell Park Cancer Institute, State University of New York, Buffalo, New York 14263, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Surgical Oncology, Roswell Park Cancer Institute, State University of New York, Buffalo, New York 14263</wicri:regionArea><wicri:noRegion>New York 14263</wicri:noRegion></affiliation></author><author><name sortKey="Kane, John M" sort="Kane, John M" uniqKey="Kane J" first="John M" last="Kane">John M. Kane</name></author><author><name sortKey="Guadagnolo, Beverly A" sort="Guadagnolo, Beverly A" uniqKey="Guadagnolo B" first="Beverly A" last="Guadagnolo">Beverly A. Guadagnolo</name></author><author><name sortKey="Kraybill, William G" sort="Kraybill, William G" uniqKey="Kraybill W" first="William G" last="Kraybill">William G. Kraybill</name></author><author><name sortKey="Ballo, Matthew T" sort="Ballo, Matthew T" uniqKey="Ballo M" first="Matthew T" last="Ballo">Matthew T. Ballo</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="RBID">pubmed:19701906</idno><idno type="pmid">19701906</idno><idno type="doi">10.1002/cncr.24627</idno><idno type="wicri:Area/PubMed/Corpus">002D70</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002D70</idno><idno type="wicri:Area/PubMed/Curation">002D70</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002D70</idno><idno type="wicri:Area/PubMed/Checkpoint">002D70</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002D70</idno><idno type="wicri:Area/Ncbi/Merge">003576</idno><idno type="wicri:Area/Ncbi/Curation">003576</idno><idno type="wicri:Area/Ncbi/Checkpoint">003576</idno><idno type="wicri:doubleKey">0008-543X:2009:Agrawal S:the:benefits:of</idno><idno type="wicri:Area/Main/Merge">006068</idno><idno type="wicri:Area/Main/Curation">005F97</idno><idno type="wicri:Area/Main/Exploration">005F97</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.</title><author><name sortKey="Agrawal, Shefali" sort="Agrawal, Shefali" uniqKey="Agrawal S" first="Shefali" last="Agrawal">Shefali Agrawal</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgical Oncology, Roswell Park Cancer Institute, State University of New York, Buffalo, New York 14263, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Surgical Oncology, Roswell Park Cancer Institute, State University of New York, Buffalo, New York 14263</wicri:regionArea><wicri:noRegion>New York 14263</wicri:noRegion></affiliation></author><author><name sortKey="Kane, John M" sort="Kane, John M" uniqKey="Kane J" first="John M" last="Kane">John M. Kane</name></author><author><name sortKey="Guadagnolo, Beverly A" sort="Guadagnolo, Beverly A" uniqKey="Guadagnolo B" first="Beverly A" last="Guadagnolo">Beverly A. Guadagnolo</name></author><author><name sortKey="Kraybill, William G" sort="Kraybill, William G" uniqKey="Kraybill W" first="William G" last="Kraybill">William G. Kraybill</name></author><author><name sortKey="Ballo, Matthew T" sort="Ballo, Matthew T" uniqKey="Ballo M" first="Matthew T" last="Ballo">Matthew T. Ballo</name></author></analytic><series><title level="j">Cancer</title><idno type="ISSN">0008-543X</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Combined Modality Therapy</term><term>Female</term><term>Humans</term><term>Lymph Node Excision</term><term>Lymphatic Metastasis</term><term>Male</term><term>Melanoma (mortality)</term><term>Melanoma (pathology)</term><term>Melanoma (radiotherapy)</term><term>Melanoma (surgery)</term><term>Middle Aged</term><term>Neoplasm Recurrence, Local</term><term>Radiotherapy Dosage</term><term>Radiotherapy, Adjuvant</term><term>Risk</term><term>Skin Neoplasms (mortality)</term><term>Skin Neoplasms (pathology)</term><term>Skin Neoplasms (radiotherapy)</term><term>Skin Neoplasms (surgery)</term><term>Survival Rate</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Association thérapeutique</term><term>Dosimétrie en radiothérapie</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie</term><term>Mâle</term><term>Mélanome ()</term><term>Mélanome (anatomopathologie)</term><term>Mélanome (mortalité)</term><term>Mélanome (radiothérapie)</term><term>Métastase lymphatique</term><term>Radiothérapie adjuvante</term><term>Risque</term><term>Récidive tumorale locale</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Taux de survie</term><term>Tumeurs cutanées ()</term><term>Tumeurs cutanées (anatomopathologie)</term><term>Tumeurs cutanées (mortalité)</term><term>Tumeurs cutanées (radiothérapie)</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Mélanome</term><term>Tumeurs cutanées</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Melanoma</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Mélanome</term><term>Tumeurs cutanées</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Melanoma</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Melanoma</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Mélanome</term><term>Tumeurs cutanées</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Melanoma</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Combined Modality Therapy</term><term>Female</term><term>Humans</term><term>Lymph Node Excision</term><term>Lymphatic Metastasis</term><term>Male</term><term>Middle Aged</term><term>Neoplasm Recurrence, Local</term><term>Radiotherapy Dosage</term><term>Radiotherapy, Adjuvant</term><term>Risk</term><term>Survival Rate</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Association thérapeutique</term><term>Dosimétrie en radiothérapie</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie</term><term>Mâle</term><term>Mélanome</term><term>Métastase lymphatique</term><term>Radiothérapie adjuvante</term><term>Risque</term><term>Récidive tumorale locale</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Taux de survie</term><term>Tumeurs cutanées</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The objective of this study was to evaluate the impact of adjuvant radiation therapy (RT) on regional recurrence and survival after therapeutic lymphadenectomy (TL) for clinically advanced, lymph node-metastatic melanoma.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country></list><tree><noCountry><name sortKey="Ballo, Matthew T" sort="Ballo, Matthew T" uniqKey="Ballo M" first="Matthew T" last="Ballo">Matthew T. Ballo</name><name sortKey="Guadagnolo, Beverly A" sort="Guadagnolo, Beverly A" uniqKey="Guadagnolo B" first="Beverly A" last="Guadagnolo">Beverly A. Guadagnolo</name><name sortKey="Kane, John M" sort="Kane, John M" uniqKey="Kane J" first="John M" last="Kane">John M. Kane</name><name sortKey="Kraybill, William G" sort="Kraybill, William G" uniqKey="Kraybill W" first="William G" last="Kraybill">William G. Kraybill</name></noCountry><country name="États-Unis"><noRegion><name sortKey="Agrawal, Shefali" sort="Agrawal, Shefali" uniqKey="Agrawal S" first="Shefali" last="Agrawal">Shefali Agrawal</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005F97 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005F97 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:19701906
|texte= The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:19701906" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |